Form 4: Orchestra BioMed Holdings Insider Darren Sherman Reports Routine Share Withholding for Tax Obligations
Insider Transaction Report
Darren Sherman, President and COO of Orchestra BioMed Holdings, Inc., reported a routine disposition of 45,843 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting, with no market sales occurring.
Summary
- Darren Sherman, President and Chief Operating Officer, and a Director of Orchestra BioMed Holdings, Inc. (OBIO), reported a transaction on May 28, 2025.
- The transaction involved the disposition of 45,843 shares of Common Stock, valued at $2.95 per share, to satisfy tax withholding obligations.
- This disposition was a withholding of shares by the Issuer in connection with the vesting of restricted stock units.
- No shares were sold in the open market as a result of this transaction.
- Following this transaction, Darren Sherman beneficially owns 803,837 shares of Common Stock directly.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While there's a reduction in shares, it's explicitly stated to be for tax withholding, not a discretionary market sale, which is generally viewed as a non-negative, routine event.
Positives
- The document explicitly states that no shares were sold in the market, clarifying that the disposition was solely for tax withholding purposes, which can prevent negative market perception often associated with insider sales.
Negatives
- The beneficial ownership of Darren Sherman decreased by 45,843 shares due to the tax withholding.
Future Outlook
N/A
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, common across all industries when executives' equity awards vest and tax obligations are met through share withholding. It does not provide broader industry context.
Stakeholder Impact
- Shareholders: A minor, non-discretionary reduction in insider ownership, which is a routine event and not indicative of a lack of confidence by the insider.
Key Dates
| Date | Description |
|---|---|
| 05/28/2025 | Date of transaction involving the disposition of shares for tax withholding. |
| 05/30/2025 | Date the Form 4 was signed by the attorney-in-fact for Darren Sherman. |
Keywords
Orchestra BioMed Holdings, OBIO, Darren Sherman, Form 4, Insider Transaction, Restricted Stock Units, Tax Withholding, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.